Drug Transporter (DT) Information

General Information of DT
DT ID DTD0016
Gene Name ABCC5
Protein Name Multidrug resistance-associated protein 5
Gene ID
10057
UniProt ID
O15440
TCDB ID
3.A.1.208.15
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 5UJ9_A

Identity: 38.53%

Minimized Score: -2759.769 kcal/mol

Detail: Structure Info

Synonyms ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11
DT Family ATP-Binding Cassette (ABC) Superfamily
Drug Conjugate Transporter (DCT) Family (ABCC)
Tissue Specificity All isoforms are equally expressed in retina.
Function This transporter acts as a multispecific organic anion pump which can transport nucleotide analogs.
Disease(s) Colorectal cancer [ICD-11: 2B91]
Cytomegalovirus infections [ICD-11: 1D82]
Malignant pleural mesothelioma [ICD-11: 2C26.0]
Cholangiocarcinoma [ICD-11: 2C12.10]
Endogenous Substrate(s) 5'-FUMP; 9-(2-phosphonylmethoxyethyl)adenine; Antimonial tartrate; Folic acids; Glutamate derivatives; Glutathione conjugates; Nucleoside analogues; Nucleotide analogues; Organoanions; Reduced folates; cAMP; cGMP
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:          10 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Adenosine
 Approved Drug Info Anxiety MB24.3 [1]
Fluorescein
 Approved Drug Info Ocular disease 9E1Z [2]
Fluorouracil
 Approved Drug Info Stomach cancer 2B72 [3]
Folic acid
 Approved Drug Info Vitamin deficiency 5B55-5B7Z [4]
Ganciclovir
 Approved Drug Info Cytomegalovirus infections 1D82 [5]
Gemcitabine
 Approved Drug Info Cholangiocarcinoma 2C12.10 [6]
Irinotecan
 Approved Drug Info Colorectal cancer 2B91 [7]
Mercaptopurine
 Approved Drug Info Acute lymphoblastic leukemia 2B33.0 [8]
Methotrexate
 Approved Drug Info Leukemia 2A60-2B33 [4]
Pemetrexed
 Approved Drug Info Malignant pleural mesothelioma 2C26.0 [9]

Endogenous Metabolites (EMs) Handled by This DT

 Endogenous Metabolites (EMs)

 Click to Show/Hide the Full List of EMs:            1 EMs in Total
EM Name PubChem CID Detail Experimental Material Ref
Octadecenylcarnitine
53481695
EM Info Identified using HEK293 cells-ABCC5 [10]

Drug-DT Affinity Assessed by Cell Line

 Approved Drug

 Click to Show/Hide the Full List of Drug:            4 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Folic acid Approved Drug Info Human embryonic kidney cells (HEK293)-MRP5 Km = 1000 microM [4]
Methotrexate Approved Drug Info Human embryonic kidney cells (HEK293)-MRP5 Km = 1174 microM [9]
Methotrexate Approved Drug Info Human embryonic kidney cells (HEK293)-MRP5 Km = 1200 microM [4]
Pemetrexed Approved Drug Info Human embryonic kidney cells (HEK293)-MRP5 Km = 281 microM [9]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Carboxydichlorofluorescein Investigative Drug Info Human embryonic kidney cells (HEK293)-MRP5 Km = 11.6 microM [9]
Cyclic adenosine monophosphate Investigative Drug Info Chinese hamster V79 cells (V79)-MRP5 Km = 379 microM [11]
References
1 Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci. 2002;4(3):E14.
2 Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem. 2007 Jul 20;282(29):20999-1004.
3 ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology. 2009;9(1-2):136-44.
4 The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res. 2005 May 15;65(10):4425-30.
5 Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005;37(1):253-78.
6 Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia. 2010 Sep;12(9):740-7.
7 Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Curr Cancer Drug Targets. 2008 Aug;8(5):414-20.
8 Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine. Springerplus. 2014 Dec 13;3:732.
9 Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur J Pharm Sci. 2006 Apr;27(5):524-32.
10 N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc Natl Acad Sci U S A. 2015 May 26;112(21):6601-6.
11 The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem. 2000 Sep 29;275(39):30069-74.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.